8C3E

Engineered mini-protein LCB2 (blocking ligand of SARS-Cov-2 spike protein)

Summary for 8C3E

• Entry DOI: 10.2210/pdb8c3e/pdb
• Descriptor: Engineered protein LCB2, GLYCEROL (3 entities in total)
• Functional Keywords: sars-cov-2, mini-protein, antiviral, blocking ligand, antiviral protein
• Biological source: synthetic construct
• Total number of polymer chains: 1
• Total formula weight: 7297.23

Authors

Korban, S.A.,Mikhailovskii, O.V.,Luzik, D.A.,Gurzhiy, V.V.,Levkina, A.D.,Kharkov, B.B.,Skrynnikov, N.R. (deposition date: 2022-12-23, release date: 2023-04-12, Last modification date: 2025-01-22)

• Primary citation: Korban, S.A.,Mikhailovskii, O.V.,Luzik, D.A.,Gurzhiy, V.V.,Levkina, A.D.,Kharkov, B.B.,Skrynnikov, N.R.; Engineered mini-protein LCB2 (blocking ligand of SARS-Cov-2 spike protein); To Be Published,

Experimental method

X-RAY DIFFRACTION (2.1 Å)